Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:3042-3044
doi: 10.1161/CIRCULATIONAHA.107.709329
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belardinelli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belardinelli, R.
Related Collections
Right arrow Congestive
Right arrow Animal models of human disease
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Circulation. 2007;115:3042-3044.)
© 2007 American Heart Association, Inc.


Editorial

Exercise Training in Chronic Heart Failure

How to Harmonize Oxidative Stress, Sympathetic Outflow, and Angiotensin II

Romualdo Belardinelli, MD

From the Cardiologia Riabilitativa e Preventiva, Lancisi Heart Institute, Ancona, Italy.

Correspondence to Romualdo Belardinelli, MD, FESC, Cardiologia Riabilitativa e Preventiva, Presidio Cardiologico G.M. Lancisi, Ospedali Riuniti, Via Conca 71–60020, Ancona, Italy. E-mail r.belardinelli@fastnet.it


Key Words: Editorials • heart failure • exercise • oxidative stress • endothelium • quality of life


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Life is movement.

— —Aristotle (fourth century bce)

Heart failure is a major clinical and public health problem in Western countries. It is estimated that nearly 23 million people have heart failure worldwide. In the United States, 550 000 new cases are reported each year, and the age at diagnosis shifted from 65±9 years in 1950 to 1969 to 80±10 in 1990 to 1999. Approximately 69% of men and 45% of women die within 5 years of the onset of symptoms.1 In the United States, half of inpatients >65 years of age with chronic heart failure (CHF) are readmitted within 6 months of hospital discharge, suggesting insufficient coordination of care among different operators and/or inefficient comprehensive discharge planning.

Articles pp 3086 and 3095

Despite the progress of medical therapy, there is no evidence that the prognosis of heart failure in the community has changed over the last decades.1 It is conceivable that more individuals are surviving an initial acute cardiac event and that the first manifestation of heart failure is delayed. Thus, heart failure is a very demanding pathology requiring personalized disease management programs that raise the costs of medical care. With the aging of the population and the decline in mortality from other pathologies, it is likely that CHF will continue to increase. In the United States, the number of new cases of heart failure is expected to rise from 3 million in 1990 to 5.7 million in 2030.

There is evidence that oxidative stress is elevated in CHF . . . [Full Text of this Article]


Related Article:

Issue Highlights
Circulation 2007 115: 3039. [Extract] [Full Text]